AAAAAA

   
Results: 1-16 |
Results: 16
CYCLOSPORINE TROUGH CONCENTRATIONS IN PREDICTING ALLOGRAFT-REJECTION AND RENAL TOXICITY UP TO 12 MONTHS AFTER RENAL-TRANSPLANTATION
Authors: MIN DI PERRY PJ CHEN HY HUNSICKER LG
Citation: Di. Min et al., CYCLOSPORINE TROUGH CONCENTRATIONS IN PREDICTING ALLOGRAFT-REJECTION AND RENAL TOXICITY UP TO 12 MONTHS AFTER RENAL-TRANSPLANTATION, Pharmacotherapy, 18(2), 1998, pp. 282-287
AN ABBREVIATED AREA-UNDER-THE-CURVE MONITORING FOR TACROLIMUS IN PATIENTS WITH LIVER-TRANSPLANTS
Authors: KU YM MIN DI
Citation: Ym. Ku et Di. Min, AN ABBREVIATED AREA-UNDER-THE-CURVE MONITORING FOR TACROLIMUS IN PATIENTS WITH LIVER-TRANSPLANTS, Therapeutic drug monitoring, 20(2), 1998, pp. 219-223
EFFECT OF GRAPEFRUIT JUICE ON THE PHARMACOKINETICS OF MICROEMULSION CYCLOSPORINE AND ITS METABOLITE IN HEALTHY-VOLUNTEERS - DOES THE FORMULATION DIFFERENCE MATTER
Authors: KU YM MIN DI FLANIGAN M
Citation: Ym. Ku et al., EFFECT OF GRAPEFRUIT JUICE ON THE PHARMACOKINETICS OF MICROEMULSION CYCLOSPORINE AND ITS METABOLITE IN HEALTHY-VOLUNTEERS - DOES THE FORMULATION DIFFERENCE MATTER, Journal of clinical pharmacology, 38(10), 1998, pp. 959-965
TIME-DEPENDENT DISPOSITION OF TACROLIMUS AND ITS EFFECT ON ENDOTHELIN-1 IN LIVER ALLOGRAFT RECIPIENTS
Authors: MIN DI CHEN HY LEE MK ASHTON K MARTIN MF
Citation: Di. Min et al., TIME-DEPENDENT DISPOSITION OF TACROLIMUS AND ITS EFFECT ON ENDOTHELIN-1 IN LIVER ALLOGRAFT RECIPIENTS, Pharmacotherapy, 17(3), 1997, pp. 457-463
SAFETY AND TOLERABILITY OF CYCLOSPORINE MICROEMULSION VERSUS CYCLOSPORINE - 2-YEAR DATA IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS - A REPORT OFTHE NEORAL STUDY-GROUP
Authors: PESCOVITZ MD BARONE G CHOC MG HRICIK DE HWANG DS JIN JHJ KLEIN JB MARSH CL MIN DI POLLAK R PRUETT TL STINSON JB THOMPSON JS VAZQUES E WAID T WOMBOLT DG WONG RL
Citation: Md. Pescovitz et al., SAFETY AND TOLERABILITY OF CYCLOSPORINE MICROEMULSION VERSUS CYCLOSPORINE - 2-YEAR DATA IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS - A REPORT OFTHE NEORAL STUDY-GROUP, Transplantation, 63(5), 1997, pp. 778-780
ARTIFICIAL NEURAL-NETWORK PREDICTION OF CYCLOSPORINE DOSE IN LIVER-TRANSPLANT PATIENTS
Authors: HERMAN RA MIN DI
Citation: Ra. Herman et Di. Min, ARTIFICIAL NEURAL-NETWORK PREDICTION OF CYCLOSPORINE DOSE IN LIVER-TRANSPLANT PATIENTS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 81-81
EFFECT OF GRAPEFRUIT JUICE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF QUINIDINE IN HEALTHY-VOLUNTEERS
Authors: MIN DI KU YM GERAETS DR LEE HC
Citation: Di. Min et al., EFFECT OF GRAPEFRUIT JUICE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF QUINIDINE IN HEALTHY-VOLUNTEERS, Journal of clinical pharmacology, 36(5), 1996, pp. 469-476
SAFETY AND TOLERABILITY OF NEORAL VS SANDIMMUNE - 1-YEAR DATA IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS
Authors: BARONE G BUNKE CM CHOC MG HRICIK DE JIN JHJ KLEIN JB MARSH CL MIN DI PESCOVITZ MD POLLAK R PRUETT TL STINSON JB THOMPSON JS VASQUEZ E WAID T WOMBOLT DG WONG RL
Citation: G. Barone et al., SAFETY AND TOLERABILITY OF NEORAL VS SANDIMMUNE - 1-YEAR DATA IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS, Transplantation proceedings, 28(4), 1996, pp. 2183-2186
EFFECT OF GRAPEFRUIT JUICE ON CYCLOSPORINE PHARMACOKINETICS IN RENAL-TRANSPLANT PATIENTS
Authors: MIN DI KU YM PERRY PJ UKAH FO ASHTON K MARTIN MF HUNSICKER LG
Citation: Di. Min et al., EFFECT OF GRAPEFRUIT JUICE ON CYCLOSPORINE PHARMACOKINETICS IN RENAL-TRANSPLANT PATIENTS, Transplantation, 62(1), 1996, pp. 123-125
THE PHARMACOKINETICS OF A MICROEMULSION FORMULATION OF CYCLOSPORINE IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS
Authors: BARONE G CHANG CT CHOC MG KLEIN JB MARSH CL MELIGENI JA MIN DI PESCOVITZ MD POLLAK R PRUETT TL STINSON JB THOMPSON JS VASQUEZ E WAID T WOMBOLT DG WONG RL
Citation: G. Barone et al., THE PHARMACOKINETICS OF A MICROEMULSION FORMULATION OF CYCLOSPORINE IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS, Transplantation, 61(6), 1996, pp. 875-880
THE SAFETY AND TOLERABILITY OF CYCLOSPORINE EMULSION VERSUS CYCLOSPORINE IN A RANDOMIZED, DOUBLE-BLIND COMPARISON IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS
Authors: BARONE G BUNKE CM CHOC MG HRICIK DE JIN JHJ KLEIN JB MARSH CL MIN DI PESCOVITZ MD POLLAK R PRUETT TL STINSON JB THOMPSON JS VASQUEZ E WAID T WOMBOLT DG WONG RL
Citation: G. Barone et al., THE SAFETY AND TOLERABILITY OF CYCLOSPORINE EMULSION VERSUS CYCLOSPORINE IN A RANDOMIZED, DOUBLE-BLIND COMPARISON IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS, Transplantation, 61(6), 1996, pp. 968-970
COMPATIBILITY OF TACROLIMUS INJECTION WITH CIMETIDINE HYDROCHLORIDE INJECTION IN 0.9-PERCENT SODIUM-CHLORIDE INJECTION
Authors: KU YM MIN DI KUMAR V NOORMOHAMED SE
Citation: Ym. Ku et al., COMPATIBILITY OF TACROLIMUS INJECTION WITH CIMETIDINE HYDROCHLORIDE INJECTION IN 0.9-PERCENT SODIUM-CHLORIDE INJECTION, American journal of health-system pharmacy, 52(18), 1995, pp. 2024-2025
EFFECT OF ERYTHROMYCIN ON ETHANOLS PHARMACOKINETICS AND PERCEPTION OFINTOXICATION
Authors: MIN DI NOORMOHAMED SE FLANIGAN MJ
Citation: Di. Min et al., EFFECT OF ERYTHROMYCIN ON ETHANOLS PHARMACOKINETICS AND PERCEPTION OFINTOXICATION, Pharmacotherapy, 15(2), 1995, pp. 164-169
OUTCOMES OF PREGNANCY AND THE MANAGEMENT OF IMMUNOSUPPRESSIVE AGENTS TO MINIMIZE FETAL RISKS IN ORGAN TRANSPLANT PATIENTS
Authors: HUYNH LA MIN DI
Citation: La. Huynh et Di. Min, OUTCOMES OF PREGNANCY AND THE MANAGEMENT OF IMMUNOSUPPRESSIVE AGENTS TO MINIMIZE FETAL RISKS IN ORGAN TRANSPLANT PATIENTS, The Annals of pharmacotherapy, 28(12), 1994, pp. 1355-1357
ENCEPHALOPATHY ASSOCIATED WITH MUROMONAB-CD3
Authors: MIN DI FALLO SA
Citation: Di. Min et Sa. Fallo, ENCEPHALOPATHY ASSOCIATED WITH MUROMONAB-CD3, Clinical pharmacy, 12(8), 1993, pp. 610-612
PREVENTION AND TREATMENT OF PNEUMOCYSTIS PNEUMONIA
Authors: MIN DI NOORMOHAMED SE
Citation: Di. Min et Se. Noormohamed, PREVENTION AND TREATMENT OF PNEUMOCYSTIS PNEUMONIA, The New England journal of medicine, 328(21), 1993, pp. 1569-1569
Risultati: 1-16 |